Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE (1995) Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study Coronary Artery Risk Development in (Young) Adults. Circulation 92(4):785–789. https://doi.org/10.1161/01.cir.92.4.785
Article CAS PubMed Google Scholar
Norrish G, Cleary A, Field E, Cervi E, Boleti O, Ziółkowska L et al (2022) Clinical features and natural history of preadolescent nonsyndromic hypertrophic cardiomyopathy. J Am Coll Cardiol 79(20):1986–1997. https://doi.org/10.1016/j.jacc.2022.03.347
Article PubMed PubMed Central Google Scholar
Pagano M, Fumagalli C, Girolami F, Passantino S, Gozzini A, Brambilla A et al (2023) Clinical profile and outcome of cardiomyopathies in infants and children seen at a tertiary centre. Int J Cardiol 371:516–522. https://doi.org/10.1016/j.ijcard.2022.09.034
Article CAS PubMed Google Scholar
Maron BJ, Desai MY, Nishimura RA, Spirito P, Rakowski H, Towbin JA et al (2022) Diagnosis and evaluation of hypertrophic cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardiol 79(4):372–389. https://doi.org/10.1016/j.jacc.2021.12.002
Norrish G, Topriceanu C, Qu C, Field E, Walsh H, Ziółkowska L et al (2022) The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathy. Eur J Prev Cardiol 29(4):645–653. https://doi.org/10.1093/eurjpc/zwab046
Wolf CM (2019) Hypertrophic cardiomyopathy: genetics and clinical perspectives. Cardiovasc Diagn Ther 9(Suppl 2):S388–S415. https://doi.org/10.21037/cdt.2019.02.01
Article PubMed PubMed Central Google Scholar
Marston NA, Han L, Olivotto I, Day SM, Ashley EA, Michels M et al (2021) Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy. Eur Heart J 42(20):1988–1996. https://doi.org/10.1093/eurheartj/ehab148
Article CAS PubMed PubMed Central Google Scholar
Lynch A, Tatangelo M, Ahuja S, Steve Fan CP, Min S, Lafreniere-Roula M et al (2023) Risk of sudden death in patients with RASopathy hypertrophic cardiomyopathy. J Am Coll Cardiol 81(11):1035–1045. https://doi.org/10.1016/j.jacc.2023.01.012
Article CAS PubMed Google Scholar
Östman-Smith I, Sjöberg G, Alenius Dahlqvist J, Larsson P, Fernlund E (2021) Sudden cardiac death in childhood hypertrophic cardiomyopathy is best predicted by a combination of electrocardiogram risk-score and HCMRisk-Kids score. Acta Paediatr 110(11):3105–3115. https://doi.org/10.1111/apa.16045
Article CAS PubMed Google Scholar
Binder J, Ommen SR, Gersh BJ, Van Driest SL, Tajik AJ, Nishimura RA, Ackerman MJ (2006) Echocardiography-guided genetic testing in hypertrophic cardiomyopathy: septal morphological features predict the presence of myofilament mutations. Mayo Clin Proc 81(4):459–467. https://doi.org/10.4065/81.4.459
Mathew J, Zahavich L, Lafreniere-Roula M, Wilson J, George K, Benson L et al (2018) Utility of genetics for risk stratification in pediatric hypertrophic cardiomyopathy. Clin Genet 93(2):310–319. https://doi.org/10.1111/cge.13157
Article CAS PubMed Google Scholar
Burstein DS, Gaynor JW, Griffis H, Ritter A, Connor MJO, Rossano JW et al (2021) Genetic variant burden and adverse outcomes in pediatric cardiomyopathy. Pediatr Res 89(6):1470–1476. https://doi.org/10.1038/s41390-020-1101-5
Article CAS PubMed Google Scholar
Fernlund E, Liuba P, Carlson J, Platonov P, Schlegel T (2016) MYBPC3 hypertrophic cardiomyopathy can be detected by using advanced ECG in children and young adults. J Electrocardiol 49(3):392–400. https://doi.org/10.1016/j.jelectrocard.2016.03.001
Article CAS PubMed Google Scholar
Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, et al (2011) 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 124(24):e783–e831. https://doi.org/10.1161/CIR.0b013e318223e2bd
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, ACMG Laboratory Quality Assurance Committee et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405–424. https://doi.org/10.1038/gim.2015.30
Article PubMed PubMed Central Google Scholar
Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alföldi J, Wang Q et al (2020) The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581(7809):434–443. https://doi.org/10.1038/s41586-020-2308-7 (Erratum in Nature 2021;590(7846):E53. Erratum in Nature 2021;597(7874):E3–E4)
Article CAS PubMed PubMed Central Google Scholar
Kampmann C, Wiethoff CM, Wenzel A, Stolz G, Betancor M, Wippermann CF et al (2000) Normal values of M mode echocardiographic measurements of more than 2000 healthy infants and children in central Europe. Heart 83(6):667–672. https://doi.org/10.1136/heart.83.6.667
Article CAS PubMed PubMed Central Google Scholar
Drezner JA, Ackerman MJ, Anderson J et al (2013) Electrocardiographic interpretation in athletes: the ‘Seattle criteria.’ Br J Sports Med 47(3):122–124. https://doi.org/10.1136/bjsports-2012-092067
Guerrier K, Anderson JB, Pratt J, King EC, Statile C, Wilmot I et al (2015) Correlation of precordial voltages to left ventricular mass on echocardiogram in adolescent patients with hypertrophic cardiomyopathy compared with that in adolescent athletes. Am J Cardiol 115(7):956–961. https://doi.org/10.1016/j.amjcard.2015.01.025
Lakdawala NK, Thune JJ, Maron BJ, Cirino AL, Havndrup O, Bundgaard H et al (2011) Electrocardiographic features of sarcomere mutation carriers with and without clinically overt hypertrophic cardiomyopathy. Am J Cardiol 108(11):1606–1613. https://doi.org/10.1016/j.amjcard.2011.07.019
Article PubMed PubMed Central Google Scholar
Alboliras ET, Shub C, Gomez MR, Edwards WD, Hagler DJ, Reeder GS et al (1986) Spectrum of cardiac involvement in Friedreich’s ataxia: clinical, electrocardiographic and echocardiographic observations. Am J Cardiol 58(6):518–524. https://doi.org/10.1016/0002-9149(86)90026-3
Article CAS PubMed Google Scholar
Panza JA, Maron BJ (1989) Relation of electrocardiographic abnormalities to evolving left ventricular hypertrophy in hypertrophic cardiomyopathy during childhood. Am J Cardiol 63(17):1258–1265. https://doi.org/10.1016/0002-9149(89)90187-2
Article CAS PubMed Google Scholar
Miron A, Lafreniere-Roula M, Steve Fan CP, Armstrong KR, Dragulescu A, Papaz T et al (2020) A validated model for sudden cardiac death risk prediction in pediatric hypertrophic cardiomyopathy. Circulation 142(3):217–229. https://doi.org/10.1161/CIRCULATIONAHA.120.047235
Article PubMed PubMed Central Google Scholar
Kamp NJ, Chery G, Kosinski AS, Desai MY, Wazni O, Schmidler GS et al (2021) Risk stratification using late gadolinium enhancement on cardiac magnetic resonance imaging in patients with hypertrophic cardiomyopathy: a systematic review and meta-analysis. Prog Cardiovasc Dis 66:10–16. https://doi.org/10.1016/j.pcad.2020.11.001
Ali LA, Marrone C, Martins DS, Khraiche D, Festa P, Martini N et al (2022) Prognostic factors in hypertrophic cardiomyopathy in children: an MRI based study. Int J Cardiol 364:141–147. https://doi.org/10.1016/j.ijcard.2022.06.043
Rowin EJ, Maron BJ, Olivotto I, Maron MS (2017) Role of exercise testing in hypertrophic cardiomyopathy. JACC Cardiovasc Imaging 10(11):1374–1386. https://doi.org/10.1016/j.jcmg.2017.07.016
Conway J, Min S, Villa C, Weintraub RG, Nakano S, Godown J et al (2023) The prevalence and association of exercise test abnormalities with sudden cardiac death and transplant-free survival in childhood hypertrophic cardiomyopathy. Circulation 147(9):718–727. https://doi.org/10.1161/CIRCULATIONAHA.122.062699
留言 (0)